Actively Recruiting
Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion
Led by Olivier F. Bertrand · Updated on 2026-01-26
500
Participants Needed
1
Research Sites
81 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Randomized study comparing the systematic use of heparin (standard of care) against an elective use of heparin to prevent radial artery occlusion after a percutaneous catheterization using a dual-artery compression system.
CONDITIONS
Official Title
Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any patient referred for a diagnostic transradial catheterism
You will not qualify if you...
- Unable to understand study design or provide informed consent
- Unable to receive antiplatelet therapy with aspirin and/or clopidogrel-prasugrel and/or ticagrelor and intravenous anticoagulant derived from heparin or bivalirudine
- Local condition such as hematoma or pseudo-aneurysm precluding radial or ulnar access
- Presence of plethysmographic waveform with simultaneous radial and ulnar occlusive compression precluding evaluation of patent hemostasis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IUCPQ
Québec, Quebec, Canada, G1V4G5
Actively Recruiting
Research Team
M
Michele Jadin
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here